An increase in right atrial blood pressure during exercise in people with pulmonary hypertension…
Steve Bryson, PhD
Steve holds a PhD in biochemistry from the Faculty of Medicine at the University of Toronto, Canada. As a medical scientist for 18 years, he worked in both academia and industry, where his research focused on the discovery of new vaccines and medicines to treat inflammatory disorders and infectious diseases. Steve is a published author in multiple peer-reviewed scientific journals and a patented inventor.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Steve Bryson, PhD
Off-label use of prostacyclin therapy successfully treated five newborns with persistent pulmonary…
New variants in the DNA region that promote the activity of the BMPR2…
Elevated levels of the protein IGFBP2 were identified in the blood of people with…
For the first time, the long-term use of antipsychotic medications has been linked to the development of…
Adults with chronic thromboembolic pulmonary hypertension (CTEPH) experience more breathing stoppages during sleep…
Volibris (ambrisentan) given to treat adults in China with pulmonary arterial hypertension…
A case report found a patient’s pulmonary arterial hypertension (PAH) was caused by an undiagnosed case of the…
Tyvaso (inhaled treprostinil) significantly improved the exercise capacity of people with World Health…
Newborns were seen to be at an increased risk of pulmonary hypertension (PH)…
People with pulmonary arterial hypertension (PAH) who were treated with…
Newly published research has detailed the underlying biochemical process behind Acceleron Pharma’s investigational…